Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug capecitabine. Lapatinib is a human epidermal growth factor receptor type 2 (HER2...
Indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and who have received prior therapy including an anthracycline, a taxane, and trastuzumab.
Samsung Medical Center, Seoul, Korea, Korea, Republic of
Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, Spain
Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain
Hospital de Torrevieja, Torrevieja, Alicante, Spain
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Florida Cancer Specialists - South, Fort Myers, Florida, United States
Oncology Hematology Care Inc., Cincinnati, Ohio, United States
Florida Cancer Specialists-North, Saint Petersburg, Florida, United States
Klinikum Esslingen, Esslingen, Baden-Württemberg, Germany
Niels-Stensen-Kliniken, Georgsmarienhütte, Niedersachsen, Germany
SLK Kliniken, Heilbronn, Baden-Württemberg, Germany
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Alabama at Birmingham, Birmingham, Alabama, United States
MD Anderson, Houston, Texas, United States
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Memorial Sloan-Kettering Cancer Commack, Commack, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, Maryland, United States
University of California San Diego Medical Center - Hillcrest, San Diego, California, United States
Sharp Memorial Hospital, San Diego, California, United States
Tennessee Oncology, Nashville, Tennessee, United States
Florida Cancer Specialists-North, St. Petersburg, Florida, United States
Chattanooga Oncology and Hematology Associates, Chattanooga, Tennessee, United States
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.